Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q4 2022 Earnings Conference Call April 3, 2023 8:00 AM ET Company Participants Alex Lobo - Stern Investor Relations Milton Werner - President & Chief Executive Officer Joe Frattaroli - Chief Financial Officer Conference Call Participants Operator Good morning and welcome to the Inhibikase Fourth Quarter and Full Year 2022 Earnings Conference Call. [Operator Instructions] Please note, today's event is being recorded. I would now like to turn the conference over to A ...